Following Cathie Wood: Continue to increase position in eVTOL leader JOBY; sell medical testing hardware company

On Monday Eastern Time, after former U.S. President Trump declared that the war was basically over, market sentiment was significantly boosted, with the three major indices closing collectively higher, and the Nasdaq rising more than 1%.

After two days of aggressive bargain hunting, overnight rebound trading has slowed down for 'Woodie' (Cathie Wood): the flow of overnight funds is revealing a harsh reality: in the AI era, companies that merely provide 'tools' or 'components' are losing their premium, while platform-type companies that can control real-world data and application scenarios are becoming the ultimate target for capital.

Buying focus: Continued emphasis on low-altitude economy

Cathie Wood continues to increase her position in the leading electric vertical takeoff and landing aircraft (eVTOL) company $Joby Aviation (JOBY.US)$ 27,800 shares. According to the main investment theme in cutting-edge industries: components are the core in the early stages, complete systems are the current commercial carriers, but embodied intelligence is the ultimate barrier to building long-term competitiveness. eVTOL is essentially the strongest 'complete system carrier' that elevates embodied intelligence and autonomous driving into three-dimensional low-altitude space. ARK's continuous accumulation of JOBY shares over multiple days reflects its bet with real money that such companies will be the first to close the commercial loop of air transportation networks. When component supply chains like batteries mature, whoever controls complete aircraft manufacturing and aerial operation platforms will possess the highest competitive moat.

Additionally, she increased her holdings in the sports betting giant $DraftKings (DKNG.US)$ 32,200 shares. DKNG has frequently demonstrated a 'sell high, buy low' pattern in ARK’s portfolio recently. This confirms that Cathie Wood is employing a more flexible swing trading strategy when dealing with cash-rich digital consumer entertainment assets to smooth out volatility in her overall growth stock portfolio.

Moreover, Cathie Wood increased her stake in the strategic holding company $Canton Strategic Holdings (CNTN.US)$ 37,500 shares, as well as in the genomics diagnostics company $GeneDx Holdings (WGS.US)$ 92 shares.

Selling direction: Continued offloading of medical device hardware and SaaS companies

Overnight, 'Wood姐' aggressively sold off a life sciences tools company $Standard BioTools (LAB.US)$ as much as 186,600 shares, while drastically cutting positions in a single-cell sequencing giant $10x Genomics (TXG.US)$ by 87,500 shares. This is an extremely strong industry signal. In the absence of deep restructuring by underlying AI large models and the empowerment of vast ecosystems, the room for imagination of pure standalone medical testing hardware and traditional sequencing instruments is being severely compressed. Capital is rapidly flowing out of these 'tool providers', whose growth ceilings have become apparent and are prone to price wars, into generative AI healthcare applications that can leverage AI to redesign proteins or targeted drugs.

In addition, she continued to reduce holdings in a community social platform $Nextdoor Holdings (NXDR.US)$ by 8,951 shares, as well as in an IT operations SaaS $PagerDuty (PD.US)$ by 395 shares. After the bloodbath of millions of shares in previous days, today's reduction in NXDR and PD seems more like clearing out the final remnants. As AI algorithms divide attention and Copilot reshapes enterprise software, the decline of geo-social networking and traditional SaaS has become inevitable.

Futubull's [Opportunities Page] has launched a feature to track celebrity portfolio opportunities! Choose from multiple celebrity portfolios, one-click follow the moves of top investors, precisely lock in high-quality stocks, and invest with greater confidence!

175K Views